Educational Session Speakers
 /  Educational Session Speakers

Dr David Tan

Dr David Tan is a consultant medical oncologist and clinician scientist at the National University Cancer Institute, Singapore.  His primary clinical and research interests in gynaecological (ovarian, endometrial and cervical) cancers and the development of novel anti-cancer therapeutic agents.

Dr Tan graduated with a BSc in Experimental Pathology (1st Class Honours) and MBBS with Distinction from Guy’s, King’s and St Thomas’ School of Medicine, University of London, UK. He undertook training in internal medicine at Hammersmith Hospital and Guy’s and St Thomas’ Hospitals in London, and obtained his MRCP(UK) in 2005. In that same year, he was awarded a Cancer Research UK (CRUK) Clinical Research Fellowship at The Institute of Cancer Research (the academic partner institution of The Royal Marsden Hospital), London, where he did research in ovarian and breast cancers and obtained his PhD in Oncology. He subsequently completed his specialist training in Medical Oncology at The Royal Marsden Hospital, London.  After working in the Drug Development Unit at The Royal Marsden Hospital/ Institute of Cancer Research, he went on to complete another fellowship at the Princess Margaret Cancer Centre, University of Toronto, Canada, in Drug Development and Gynaecologic Oncology before returning back to Singapore.

In addition to his clinical and academic duties, he is currently also the Associate Chairman Medical Board for Research at the National University Hospital, Singapore and Head of the Innovation Transfer Office at National University Health Systems (NUHS).  He is also a member of the Novel Agents Committee for Cancer (NACC) at the Experimental Therapeutics Centre in A*STAR Singapore.

Dr Joseph Lee

Joseph K.T. Lee is a Distinguished Professor of Radiology at the University of North Carolina School of Medicine and Visiting Professor at National University of Singapore (2014 – 2016). A world-class expert in the developing technologies of computed tomography (CT) and magnetic resonance imaging (MRI), his primary area of expertise is abdominal imaging.

In the United States and abroad, Lee is known as a pioneer in the clinical utility of CT and MRI of abdominal and pelvic organs. He has written and edited seven major textbooks. His best-known book, Computed Body Tomography with MRI Correlation, is in its fourth edition and was published in 2006. He also has published more than 160 articles in refereed journals.

His research focuses on the comparison between CT and MR imaging for various abdominal and pelvic disorders, and identifies the impact that use of these new technologies can have on patient care.

Lee has also focused on enhancing productivity in academic radiology departments.

He has delivered numerous invited lectures nationally and internationally. He has served leadership positions in many professional radiologic organizations, including the office of president for the Society of Computed Tomography and MRI, the Society of Chairmen of Academic Radiology Departments and the American Roentgen Ray Society (ARRS).

Lee received Gold Medal from Asian Oceanian Society of Radiology and from ARRS. He was the recipient of Washington University School of Medicine Alumni Achievement Award and is an Honorary Member of Korean Society of Radiology as well as Japanese Society of Radiology.

Lee graduated from Washington University School of Medicine in 1973. He completed his residency training at Mallinckrodt Institute of Radiology and joined the faculty in 1977. He became a full professor in 1986. Lee left Washington University in 1991 for the University of North Carolina at Chapel Hill, where he continued to excel as chair of radiology before relinquishing his administrative duties in 2007. He now devotes his time to patient care, clinical research and mentoring the next generation of radiology leaders.

Dr Christine Dela Cruz

Christine received her medical degree from The University of Santo Tomas in the Philippines and did post-graduate training in Internal Medicine, Pulmonary Medicine, and in Lung Cancer at the University of the Philippines, Tokyo Medical College, UCLA, and the University of Nevada. Christine also holds a Masters in Health Science Management from the University of Sydney. Prior to joining BMS, Christine worked as a Medical Director for Novartis, a Regional R&D Medical Adviser and Global Clinical Program Scientist in the Pharmaceutical Development Centre of Pharmacia/Pfizer, and a Regional Medical Adviser for UCB. Previously, she also held medical teaching positions and hospital administrative positions.
Christine brings to the table 21 years of industry experience, 13 in a regional capacity covering the Asia-Pacific region.